Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131518) titled 'A Study on the Efficacy and Safety of Thioimidazole Cream Versus Hydroquinone Cream in the Treatment of Melasma' on Sept. 3.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Huashan Hospital Affiliated to Fudan University
Condition:
Melasma
Intervention:
Hydroquinone group (half-face randomized grouping):Hydroquinone Cream
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2025-02-13
Target Sample Size: Hydroquinone group (half-face randomized grouping):98;Thiourea group (half-face randomized grouping):98;
Countries of Recruitment:
China
To know more, vis...